Reperio Health
Reperio Health provides at-home preventive health screening kits delivering instant biometric results via FDA-cleared Bluetooth devices and a mobile app, serving employers, health plans, and providers with optional on-demand virtual clinician follow-up.
- Company typePrivate
- Founded2020
- HeadquartersPortland, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Reperio Health does
Reperio Health, Inc. is a Portland, Oregon-based, venture-backed private company founded in 2020 that provides at-home preventive health screening kits with instant biometric results. The company's core product, ReperioKit, combines FDA-cleared, CLIA-waived Bluetooth-connected diagnostic devices with a consumer-grade mobile application (iOS and Android) to measure blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides, delivering results in under 30 minutes rather than the weeks typical of traditional laboratory workflows. The technology is protected by a registered patent covering instant at-home screening results, which the company claims is unique globally in this category. A companion service, ReperioCare, adds an on-demand virtual preventive care visit where licensed clinicians review screening results, health history, and lifestyle risk factors to provide actionable recommendations; this service can be billed as a preventive insurance claim through employer-sponsored health plans.
The company's revenue model rests on two tiers: a Foundation tier consisting of one-time/perpetual kit sales, and a Recommended tier bundling kits with ReperioCare clinical follow-up on a pay-as-you-go cadence. Pricing is quote-based and not publicly disclosed, and the company sells with no minimum order quantities, one-click ordering, and 24/7 live support. Reperio pursues a dual go-to-market motion: direct enterprise sales to employers and health plans, and direct-to-consumer self-service ordering through its mobile app. Distribution is also augmented by a strategic partnership with Amazon One Medical (announced January 2026) that uses Reperio screening as a catalyst for One Medical membership enrollment.
Reperio's customer base spans employer wellness programs (The Partners Group, CareerPlug, Pella, Bob's Red Mill, Tailored Brands, SMX, SANW), health systems and providers (Vanderbilt Health, Children's Hospital Colorado, Methodist), and health plans/insurers (John Hancock, Presbyterian, PEHP). The company reports outcome metrics including a 200% increase in preventive screening participation versus traditional screenings, a 71% opt-in rate, a 95% customer satisfaction rate, a 48% condition discovery rate, and 4-8x client ROI. ReperioCare operations cover 39 states plus Washington D.C. as of October 2025, with a stated plan to reach all 50 states by 2026. The company is SOC 2 Type II certified and HIPAA-compliant, is led by co-founder and CEO Travis Rush with co-founder Matt Wallington as CTO, and has raised approximately $26.7 million in cumulative disclosed funding across rounds from 2021 through 2025, with Caduceus Capital Partners as lead investor in both the 2021 and 2025 rounds.
Reperio Health firmographics
Firmographics- Name
- Reperio Health
- Legal name
- Reperio Health, Inc.
- Website
- https://reperiohealth.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Reperio Health provides at-home preventive health screening kits delivering instant biometric results via FDA-cleared Bluetooth devices and a mobile app, serving employers, health plans, and providers with optional on-demand virtual clinician follow-up.
- Ownership category
- akta.pro rank
Reperio Health industry classification
Industry- Product category
- At-Home Preventive Health Screening Services
- NAICS
- Home Health Care Services (62161), Offices of Physicians (6211), Home Health Care Services (621610)
- SIC
- Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cardiology Telemedicine Platforms (HLALAGAB)
- akta.pro secondary industry
- Preventive Cardiology & Lipidology (HLAKABAF)
Keywords
Where Reperio Health is headquartered
LocationHeadquarters
- HQ city
- Portland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Reperio Health business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- ReperioKit Sales (Foundation Tier): At-home preventive screening kits sold to employers and health plans with instant results. No minimum order quantities. Includes one-click ordering, 24/7 live support, aggregate reporting, and data sharing for continuity.
- ReperioCare (Clinical Follow-up): On-demand virtual preventive care visits bundled with screening kits. Can be billed as a preventive insurance claim for employers' health plans or available via direct invoice.
- Amazon One Medical Partnership Integration: Partnership enabling Reperio-screened individuals to access One Medical memberships. Prospective and current One Medical clients can activate employees using Reperio screening as a catalyst for membership enrollment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Foundation Tier - At-home preventive screening kit with instant results |
| Subscription | Pay-as-you-go | ReperioCare - Screening with clinical follow-up virtual visit |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Reperio Health product offering
Product offeringCore offering
Reperio Health delivers at-home preventive health screenings through the ReperioKit™ — an FDA-cleared, Bluetooth-connected kit that measures blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides in under 30 minutes with instant results via a mobile app. The offering is paired with ReperioCare®, an on-demand virtual preventive care visit where licensed clinicians review screening results and provide care recommendations, billable as a preventive insurance claim for employer health plans.
Product overview
Reperio Health offers a unified preventive health platform combining at-home screening hardware (ReperioKit™), a mobile application, and integrated virtual care services (ReperioCare®). Users perform finger-stick blood tests at home, receive biomarker results via the app, and can connect with clinicians for virtual consultations to discuss their health data.
Differentiator
Problem solved
Functional benefit
Brands
- ReperioKit: At-home preventive health screening kit that measures key health indicators including blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides, delivering instant results in under 30 minutes.
- ReperioCare
Products and services
- ReperioKit™ At-home preventive health screening kit that measures blood pressure, heart rate, BMI, relative fat mass, glucose (fasting/non-fasting), total cholesterol, HDL, LDL, and triglycerides from a finger-stick blood sample via FDA-cleared Bluetooth-connected devices, delivering biometric results to the mobile app in under 30 minutes.
- ReperioCare® On-demand virtual preventive care visit in which licensed clinicians review ReperioKit screening results, health history, and lifestyle risk factors to provide actionable care recommendations and care coordination. Can be billed as a preventive insurance claim through employer-sponsored health plans.
- Reperio Health Mobile App iOS and Android mobile application that delivers instant screening results, provides guided step-by-step screening instructions, manages kit logistics, enables ReperioCare virtual visits, and supports direct consumer ordering of ReperioKit screening kits.
Quantifiable outcome
- 200% increase in preventive screening participation versus traditional screenings
- +5 more outcomes
Companies that use Reperio Health
Customer profileNamed customers13 records
Segments4 records
Ideal customer profiles4 records
Reperio Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Reperio Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Amazon One MedicalcorePartnership announced January 28, 2026 connects at-home health screenings with proactive primary care. Individuals completing Reperio's preventive screening gain direct access to One Medical membership. The collaboration creates a streamlined path from early detection to ongoing primary medical care, combining Reperio's ability to reach distributed populations with One Medical's national hybrid in-person and virtual primary care model.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Reperio Health competitors and assessment
Company assessmentDirect peers
- LetsGetChecked: LetsGetChecked provides at-home diagnostic test kits with telehealth follow-up and is a direct competitor in the at-home screening plus virtual clinician consultation model.
- Everlywell: Everlywell sells at-home lab-based health tests with optional clinician consults, directly competing in consumer and employer at-home screening.[priMetrick is augmented by Lipsum+ data that wasnt formatted properly] Actually, let me clean this up.
- BioIQ: BioIQ provides at-home biometric screening solutions targeting employers and health plans for population health management, directly comparable to Reperio's enterprise screening offering.
Broad incumbents
- Quest Diagnostics: Quest Diagnostics is a national clinical laboratory network that could bundle at-home preventive screening into its employer/payer programs as a broad incumbent in lab diagnostics.
- Labcorp: Labcorp operates a national clinical lab franchise with employer wellness offerings; it overlaps with Reperio's screening-plus-phlebotomy/lab channel as a broad incumbent.
- Teladoc Health: Teladoc is a large incumbent in virtual care that could expand from acute/specialty telehealth into at-home preventive screening kits and virtual wellness visits.
Emerging players
- Forward Health: Forward is a preventive-focused primary care provider with home body scanning; it targets employers and offers membership-based preventive care, partially overlapping with ReperioCare.
- Function Health: Function Health sells membership-based at-home lab testing panels paired with clinician insight, closely paralleling Reperio's annual screening-plus-clinician model.
- TytoCare: TytoCare provides connected at-home medical exam kits integrated with telehealth visits for clinical decision support, partially comparable to Reperio's hardware-plus-virtual-visit platform.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Reperio Health social profiles
Digital presenceReperio Health compliance and trust
Trust signalCompliance1 record
Reperio Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Reperio Health leadership team
Management profileNumber of profiles
Profiles9 records
Reperio Health funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Reperio Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Reperio Health
What does Reperio Health do?
Reperio Health delivers at-home preventive health screenings through the ReperioKit™ — an FDA-cleared, Bluetooth-connected kit that measures blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides in under 30 minutes with instant results via a mobile app. The offering is paired with ReperioCare®, an on-demand virtual preventive care visit where licensed clinicians review screening results and provide care recommendations, billable as a preventive insurance claim for employer health plans.
Is Reperio Health a public or private company?
Reperio Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Reperio Health founded?
Reperio Health was founded in 2020. It employs 11 to 50 people.
Where is Reperio Health based?
Reperio Health is headquartered in Portland, United States, in the North America region.
How does Reperio Health make money?
Three revenue lines are on record. ReperioKit Sales (Foundation Tier) is the primary driver. The others are reperioCare (Clinical Follow-up) and amazon One Medical Partnership Integration.
Who are Reperio Health's main competitors?
Direct peers on record are LetsGetChecked, Everlywell and BioIQ. Broad incumbents are Quest Diagnostics, Labcorp and Teladoc Health. Emerging players are Forward Health, Function Health and TytoCare.
Does Reperio Health have an API?
No public API is recorded for Reperio Health.
What industry is Reperio Health in?
Reperio Health's product category is At-Home Preventive Health Screening Services. Its primary akta.pro industry code is HLALAGAB, Cardiology Telemedicine Platforms, with a secondary code of HLAKABAF, Preventive Cardiology & Lipidology. Its NAICS code is 62161 and its SIC code is 8082.